Full text is available at the source.
New developments in designing and using drugs that activate PPARγ for treatment
Updated
Abstract
Synthetic PPARγ agonists are being explored for their therapeutic potential in various human disorders.
- PPARγ regulates genes involved in glucose management.
- Diverse synthetic PPARγ agonists, including thiazolidinediones and non-thiazolidinediones, are being developed.
- Recent advances highlight therapeutic applications in type 2 diabetes, liver and inflammatory diseases, cancer, and neurological disorders.
- Studies utilizing cellular, animal models, and clinical trials have been conducted over the past decade.
Simplified